BSE · VEERHEALTH.BO
Veerhealth Care Limited
₹49.18+₹0.19 (+0.39%)
Veerhealth Care Limited’s quoted price sits in the upper half of its reported 52-week range, 5.42% below the high.
Loading market information…
BSE · ROOPAIND.BO · INR
Stock price, earnings
Quote as of Oct 30, 2026, 06:08 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Roopa Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 34.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Roopa Industries Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established on June 17, 1985, Roopa Industries Ltd. is a pharmaceutical manufacturing company based in Hyderabad, India. Its product offerings include triphenyl phosphine, glucosamine, and various bromine compounds.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
₹49.18+₹0.19 (+0.39%)
Veerhealth Care Limited’s quoted price sits in the upper half of its reported 52-week range, 5.42% below the high.
₹41.64+₹1.14 (+2.81%)
Shelter Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 25.48% below the high.
₹43.45-₹0.56 (-1.27%)
Medinova Diagnostic Services Limited’s quoted price sits in the upper half of its reported 52-week range, 5.54% below the high.
₹33.00-₹1.40 (-4.07%)
ANG Lifesciences India Limited’s quoted price sits in the lower half of its reported 52-week range, 33.59% below the high.
₹143.00-₹6.95 (-4.63%)
Crestchem Limited’s quoted price sits in the upper half of its reported 52-week range, 22.7% below the high.
₹35.01-₹0.30 (-0.85%)
Sandu Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 29.98% below the high.
₹41.35-₹1.60 (-3.73%)
Gujarat Terce Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 17.3% below the high.
₹12.26+₹0.21 (+1.74%)
Deccan Health Care Ltd’s quoted price sits in the lower half of its reported 52-week range, 33.37% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
